Space alters an astronaut’s immune system
From microgravity to radiation, space wreaks havoc on astronauts’ immune systems, potentially putting them at risk of infection from microbes onboard.
Daily News
A small molecule inhibitor blocks breast cancer's back up plan
A small molecule inhibitor blocks breast cancer's back up plan
Scientists discovered a long sought-after inhibitor for the DNA repair polymerase, Polθ, which may be key to treating drug-resistant BRCA1 and BRCA2-mutant cancers.
A promising new class of psychotropic drugs
A promising new class of psychotropic drugs
A newly developed drug stabilizes dopamine and serotonin levels using a novel mechanism. It effectively treats psychosis in patients with schizophrenia, and researchers are testing its efficacy for Parkinson’s disease as well.
COVID-19 may trigger an autoimmune response
COVID-19 may trigger an autoimmune response
Researchers plan to monitor the immune responses of COVID-19 patients for one year to see how they correlate with illness severity and lasting effects. This data will help develop personalized treatments for patients.
Activating a brain circuit relieves pain in male mice, but not in female mice
Activating a brain circuit relieves pain in male mice, but not in female mice
Scientists identified a new sex-specific pain circuit in the brain, laying the groundwork for developing better pain-relieving drugs for both sexes.
Can a probiotic prevent type 1 diabetes in children?
Can a probiotic prevent type 1 diabetes in children?
An upcoming clinical study will test whether a B. infantis probiotic can prevent the development of type 1 diabetes in predisposed infants.
A promising protein degrader trashed a key oncogenic protein
A promising protein degrader trashed a key oncogenic protein
Targeting oncogenic transcription factors like MYC is challenging, but researchers found a way to target its regulator, WDR5, for degradation, exemplifying the capacity of protein degraders to target the “undruggable.”
